Marilena Vrana: Take Our New Global Survey on Patient Experiences with Plasma-Derived Medicines
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared on LinkedIn:
”Plasma Powers Possibility and Listening Powers Progress.
I’m proud to share a new global survey focused on the voices of patients who rely on plasma-derived medicines.
Building on the strong engagement across the global community in the 2025 International Plasma Awareness Week (IPAW), this is an opportunity to keep that momentum going.
Understanding awareness, experiences, and perceptions will help strengthen education and advocacy worldwide.
If you are a patient, caregiver, or healthcare professional, your voice matters!
Please take 5 minutes to complete the survey and share it with your network.
Every response makes a difference.”
Stay updated with Hemostasis Today.
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target